Neuropeptides and Neurotransmitters Involved in Generalized Epilepsy: How Can the Antiepileptic Effect be Improved?
نویسندگان
چکیده
Here, we describe the alterations of neurotransmitters and neuropeptides that act on specific subreceptors in the brain areas involved in generalized epilepsy. A neurotransmitter imbalance between GABAergic and serotonergic neurons with hypoactivity and glutaminergic and dopaminergic neurons with hyperactivity is described. Considering the alterations in neurotransmitters and neuropeptides, neural networks in the hippocampus, hypothalamus, thalamus and cortex are described. The mechanisms of action of some recently developed antiepileptic drugs are addressed. In sum, a multimodal antiepileptic pharmacotherapy acting at several specific subreceptors is suggested. We recommend the development of an antiepileptic drug, that exerts simultaneously a GABAA agonistic and an NMDA antagonistic effect.
منابع مشابه
Immunological Correlates of Adult Onset Idiopathic Generalized Tonic-clonic Epilepsy before and after Sodium Valproate Treatment
Objective: To investigate possible immunological humoral correlates in newly diagnosed adult-onset generalized tonic-clonic epilepsy among Iranian patients before and after sodium valproate treatment. Patients and Methods: 72 adult patients with newly diagnosed idiopathic generalized tonic-clonic epilepsy were recruited. Serum antinuclear antibodies (ANA), anti-cardiolipin antibodies (aCL), a...
متن کاملPregabalin Dependence : A Case Report 2
Pregabalin is a new generation antiepileptic that exerts its effect by decreasing the release of such neurotransmitters as glutamate, noradrenaline, and substance P. Pregabalin can be prescribed in Turkey at 150-600 mg to treat neuropathic pain, generalized anxiety disorder, fibromyalgia, and as concomitant therapy in adult patients with partial epilepsy. Experimental studies have shown that pr...
متن کاملChallenges in the Treatment of Epilepsy
Epilepsy is one of the most important diseases of nervous system that involves 0.5-1% of the population. In spite of new developments in antiepileptic drugs, between 20-30% of epileptic patients can not be controlled and even those who are controlled with antiepileptic drugs suffer from their adverse events. Epileptic patients have different challenges in relation to the disease and its medicat...
متن کاملPregabalin: A new antiepileptic drug for refractory epilepsy
Pregabalin is a recently licensed and marketed antiepileptic drug for use as adjunctive treatment of partial epilepsy. It acts at presynaptic calcium channels, modulating neurotransmitter release in the CNS, properties it shares with gabapentin. Its clinical development over the past decade has included its use in the treatment of neuropathic pain, and generalized anxiety disorder, in addition ...
متن کاملAntiepileptic Drugs and Mental Health Status of Patients with Epilepsy
Many patients with epilepsy suffer also from coexisting psychological problems. These mental co-morbidities have a significant impact on quality of life of patients with epilepsy. Recent studies have shown that although antiepileptic drugs (AEDs) treat epilepsy, they may increase risk of mental disorders in these patients . Due to the lack of adequate research in this area, we assess...
متن کامل